119 related articles for article (PubMed ID: 855755)
1. The influence of allopurinol in customary and in slow release preparation on different parameters of purine and pyrimidine metabolism.
Gröbner W; Walter I; Rauch-Janssen A; Zöllner N
Adv Exp Med Biol; 1977; 76B():297-303. PubMed ID: 855755
[No Abstract] [Full Text] [Related]
2. The allopurinol hypersensitivity syndrome: its relation to plasma oxypurinol levels.
Casas E; Puig JG; Mateos FA; Jiménez ML; Michán AD; Ramos TH
Adv Exp Med Biol; 1989; 253A():257-60. PubMed ID: 2624201
[No Abstract] [Full Text] [Related]
3. [Time course of oxipurinol levels in plasma following single dose and chronic administration of allopurinol in different pharmaceutical preparations (author's transl)].
Walter-Sack I; Gröbner W; Zöllner N
Arzneimittelforschung; 1979; 29(5):839-42. PubMed ID: 582985
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.
Day RO; Miners JO; Birkett DJ; Whitehead A; Naidoo D; Hayes J; Savdie E
Br J Clin Pharmacol; 1988 Oct; 26(4):423-8. PubMed ID: 3190992
[TBL] [Abstract][Full Text] [Related]
5. [Effect of osmadizone on serum uric acid as well as on renal uric acid, oxypurine and orotic acid excretion in healthy subjects].
Gröbner W; Meurer M; Zöllner N
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1527-9. PubMed ID: 1030038
[No Abstract] [Full Text] [Related]
6. Absorption and metabolism of allopurinol and oxypurinol by rat jejunum in vitro: effects on uric acid transport.
Shaw MI; Parsons DS
Clin Sci (Lond); 1984 Mar; 66(3):257-67. PubMed ID: 6692658
[TBL] [Abstract][Full Text] [Related]
7. Effect of allopurinol on pyrimidine metabolism in the Lesch-Nyhan syndrome.
Beardmore TD; Fox IH; Kelley WN
Lancet; 1970 Oct; 2(7677):830-1. PubMed ID: 4196060
[No Abstract] [Full Text] [Related]
8. Effect of furosemide on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
[TBL] [Abstract][Full Text] [Related]
9. [The influence of allopurinol on purine- and pyrimidinesynthesis (author's transl)].
Gröbner W; Zöllner N
Klin Wochenschr; 1978 Mar; 53(16):255-60. PubMed ID: 682520
[TBL] [Abstract][Full Text] [Related]
10. Allopurinol-induced suppressor T cell dysfunction.
Elion GB; Williams TE
J Am Acad Dermatol; 1982 Nov; 7(5):687-8. PubMed ID: 6216274
[No Abstract] [Full Text] [Related]
11. Potentiation of an effect of allopurinol on pyrimidine metabolism by chlorothiazide in man.
Wood MH; O'Sullivan WJ; Wilson M; Tiller DJ
Clin Exp Pharmacol Physiol; 1974; 1(1):53-8. PubMed ID: 4457266
[No Abstract] [Full Text] [Related]
12. Effect of allopurinol on pyrimidine metabolism in human white blood cells. Role of the salvage pathway.
Banholzer P; Gröbner W; Zöllner N
Adv Exp Med Biol; 1979; 122B():209-15. PubMed ID: 94760
[No Abstract] [Full Text] [Related]
13. The influence of dietary purines and pyrimidines on purine and pyrimidine biosynthesis in man.
Gröbner W; Zöllner N
Nutr Metab; 1977; 21(1-3):26-32. PubMed ID: 917350
[TBL] [Abstract][Full Text] [Related]
14. [The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application].
Fenner H; Schiemann O; Gikalov I
Arzneimittelforschung; 1985; 35(7):1093-6. PubMed ID: 4052144
[TBL] [Abstract][Full Text] [Related]
15. Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol, and purine bases between dietary intake and fasting.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):157-62. PubMed ID: 8861734
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol: a comparative study of the bioavailability and effect on plasma uric acid of two products in tablet form.
Nissen P; Pedersen L
Biopharm Drug Dispos; 1985; 6(4):441-6. PubMed ID: 4084669
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic efficacy of slow-release allopurinol in gout and hyperuricaemia (author's transl)].
Dunky A; Nitsche V; Eberl R
Wien Klin Wochenschr; 1981 Jan; 93(2):65-8. PubMed ID: 7245774
[TBL] [Abstract][Full Text] [Related]
19. [Clinical pharmacokinetics of allopurinol. 3. Allopurinol/oxipurinol pharmacokinetics following administration of a controlled release allopurinol preparation].
Gikalov I; Radivojevich F; Schiemann O; Fenner H
Arzneimittelforschung; 1986 Jun; 36(6):988-93. PubMed ID: 3741536
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
